ASTEC — Astec Lifesciences Balance Sheet
0.000.00%
- IN₹13.92bn
- IN₹19.43bn
- IN₹3.81bn
Annual balance sheet for Astec Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3.39 | 5.54 | 4.73 | 4.71 | 33.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,177 | 3,147 | 1,952 | 1,925 | 1,502 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,304 | 5,157 | 4,989 | 3,985 | 3,411 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3,232 | 3,514 | 4,292 | 5,316 | 4,967 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 6,776 | 8,968 | 9,794 | 9,749 | 8,814 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,223 | 4,906 | 5,262 | 3,972 | 3,657 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 3,684 | 5,003 | 5,601 | 6,056 | 6,467 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 3,092 | 3,965 | 4,194 | 3,693 | 2,347 |
Total Liabilities & Shareholders' Equity | 6,776 | 8,968 | 9,794 | 9,749 | 8,814 |
Total Common Shares Outstanding |